• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺功能明显受损患者的支气管源性癌局限性切除术。

Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function.

作者信息

Miller J I, Hatcher C R

机构信息

Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, GA.

出版信息

Ann Thorac Surg. 1987 Oct;44(4):340-3. doi: 10.1016/s0003-4975(10)63785-x.

DOI:10.1016/s0003-4975(10)63785-x
PMID:2821937
Abstract

Surgical resection is the treatment of choice for non-small cell bronchogenic carcinoma, and it is the only method providing prolonged arrest and chance for cure. From 1974 through 1984, 32 patients with marked impairment of pulmonary function had a limited resection for carcinoma of the lung. Marked impairment is defined as a maximum breathing capacity less than 35 to 40% of predicted, forced expiratory volume in one second less than or equal to 1 liter, and forced expiratory flow (FEV25-75) of less than or equal to 0.6 liter. Limited resection is defined as an operation that is less than a lobectomy, generally a wide wedge or segmental resection. The pathological stage of disease was Stage I in 31 patients and Stage II in 1 patient. Ten patients were treated by segmental resection and 22 by wide wedge resection. Two-year and three-year survival is 84 and 78%, respectively, and 10 patients (31%) have survived for five years. Recurrent disease developed in 8 patients, 5 of whom died. Recurrence was highest when the lesion crossed an intersegmental plane. In 1978, postoperative radiation therapy was added to the treatment of all patients whose lesion crossed an intersegmental plane. Since then, 18 patients have undergone wedge resection and postoperative irradiation with only 2 local recurrences at two years.

摘要

手术切除是非小细胞支气管肺癌的首选治疗方法,也是唯一能提供长期缓解和治愈机会的方法。1974年至1984年期间,32例肺功能严重受损的患者接受了肺癌局限性切除术。严重受损定义为最大呼吸容量低于预测值的35%至40%,一秒用力呼气量小于或等于1升,用力呼气流量(FEV25-75)小于或等于0.6升。局限性切除定义为手术范围小于肺叶切除术,通常为广泛楔形或节段性切除。疾病的病理分期为I期31例,II期1例。10例患者接受节段性切除,22例接受广泛楔形切除。两年和三年生存率分别为84%和78%,10例患者(31%)存活了五年。8例患者出现复发,其中5例死亡。当病变跨越节段间平面时,复发率最高。1978年,对所有病变跨越节段间平面的患者在治疗中增加了术后放疗。从那时起,18例患者接受了楔形切除和术后放疗,两年时仅2例局部复发。

相似文献

1
Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function.肺功能明显受损患者的支气管源性癌局限性切除术。
Ann Thorac Surg. 1987 Oct;44(4):340-3. doi: 10.1016/s0003-4975(10)63785-x.
2
Limited resection of bronchogenic carcinoma in the patient with impaired pulmonary function.
Ann Thorac Surg. 1993 Sep;56(3):769-71. doi: 10.1016/0003-4975(93)90976-o.
3
Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma.局部复发性和第二原发性支气管源性癌的迭代手术切除
Eur J Cardiothorac Surg. 2000 Nov;18(5):529-34. doi: 10.1016/s1010-7940(00)00572-8.
4
Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy.肺切除术后因支气管源性癌行二期肺切除术。
Ann Thorac Surg. 2002 Jul;74(1):154-8; discussion 158-9. doi: 10.1016/s0003-4975(02)03688-3.
5
Late outcome and perioperative complications for surgery of locally recurrent bronchogenic carcinoma.局部复发性支气管源性癌手术的远期疗效及围手术期并发症
J Cardiovasc Surg (Torino). 2005 Oct;46(5):515-8.
6
Wedge resection for bronchogenic carcinoma in high-risk patients.高危患者支气管源性癌的楔形切除术。
South Med J. 1992 Nov;85(11):1081-3. doi: 10.1097/00007611-199211000-00007.
7
Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma.支气管肺癌的支气管成形术和肺动脉重建术评估
Eur J Cardiothorac Surg. 2003 Feb;23(2):209-13. doi: 10.1016/s1010-7940(02)00743-1.
8
[Recurrence of non-small cell bronchial cancer: indications and results of surgical treatment].[非小细胞支气管癌的复发:手术治疗的指征与结果]
Pneumologie. 1990 Sep;44(9):1106-9.
9
Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.肺癌合并间质性肺疾病患者手术后的长期结果和生存预测因素。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):64-9, 70.e1-2. doi: 10.1016/j.jtcvs.2014.08.086. Epub 2014 Sep 18.
10
The influence of cardiopulmonary function on outcome of veterans undergoing resectional therapy for lung cancer.心肺功能对接受肺癌切除治疗的退伍军人预后的影响。
J Cardiovasc Surg (Torino). 1998 Aug;39(4):497-501.

引用本文的文献

1
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review.静脉注射吲哚菁绿在微创节段性肺切除术中的应用:一项系统评价
Transl Lung Cancer Res. 2024 Mar 29;13(3):612-622. doi: 10.21037/tlcr-23-807. Epub 2024 Mar 27.
2
Are Extensive Open Lung Resections for Elderly Patients with Lung Cancer Justified?老年肺癌患者行广泛开肺切除术是否合理?
Curr Oncol. 2023 Jun 5;30(6):5470-5484. doi: 10.3390/curroncol30060414.
3
Short-term local control after VATS segmentectomy and lobectomy for solid NSCLC of less than 2 cm.
VATS 段切术和肺叶切除术治疗 2cm 以下实性非小细胞肺癌的短期局部控制。
Thorac Cancer. 2021 Feb;12(4):453-461. doi: 10.1111/1759-7714.13766. Epub 2020 Dec 3.
4
Feasibility of limited resection for peripheral small-sized non-small cell lung cancer: a retrospective single-center-based study.局限性切除术治疗外周型小细胞肺癌的可行性:一项回顾性单中心研究。
J Cancer Res Clin Oncol. 2021 May;147(5):1519-1527. doi: 10.1007/s00432-020-03441-1. Epub 2020 Nov 5.
5
Brachytherapy vs external beam therapy among NSCLC patients undergoing limited surgical resection.局限性手术切除治疗非小细胞肺癌患者中近距离放疗与外照射放疗的比较。
J Cancer Res Clin Oncol. 2021 Mar;147(3):853-861. doi: 10.1007/s00432-020-03375-8. Epub 2020 Sep 17.
6
Optimal sublobar resection for c-stage I non-small cell lung cancer: significance of margin distance to tumor size ratio and margin cytology (Supplementary analysis of KLSG-0801): complete republication.c期I期非小细胞肺癌的最佳亚肺叶切除术:切缘距离与肿瘤大小比值及切缘细胞学的意义(韩国肺癌研究组KLSG-0801补充分析):全文重新发表
Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):690-696. doi: 10.1007/s11748-019-01069-8. Epub 2019 Feb 19.
7
Surgical Management of Lung Cancer: History, Evolution, and Modern Advances.肺癌的外科治疗:历史、演变和现代进展。
Curr Oncol Rep. 2018 Nov 13;20(12):98. doi: 10.1007/s11912-018-0741-7.
8
Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.验证临床 I 期非小细胞肺癌肺楔形切除术中切缘状态
Surg Today. 2018 Oct;48(10):963-967. doi: 10.1007/s00595-018-1683-2. Epub 2018 Jun 19.
9
Emerging treatment options in the management of non-small cell lung cancer.非小细胞肺癌治疗中的新兴治疗选择。
Lung Cancer (Auckl). 2011 Jun 8;2:11-28. doi: 10.2147/LCTT.S8618. eCollection 2011.
10
Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication.无法接受肺叶切除术的c期I非小细胞肺癌患者亚肺叶切除术的多中心前瞻性研究(KLSG-0801):完整再发表
Gen Thorac Cardiovasc Surg. 2016 Aug;64(8):470-5. doi: 10.1007/s11748-016-0662-z. Epub 2016 May 27.